Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Golden Cariboo (CSE:GCC) (OTC:GCCFF) Unlocks Cariboo Gold Potential (click to learn more)
An Emerging Name in Cannabis: HERB (click to learn more)
AI-Driven Wellness Play on the CSE (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
TC BioPharm Holdings PLC (PK)
TCBPY
Alternate Symbol(s):
TCBWF
Healthcare
Biotechnology
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an...
unmodified cell therapy to treat viral infections, as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (PINL:TCBPY)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(988)
•••
Iseneschal
X
Post by
Iseneschal
on May 07, 2024 10:07am
TCBP.....I warned you all yesterday just after the opening
$3.00 ....now at $1.25 Sure does suck being a Chaser doesn't it ; )
(988)
•••
Iseneschal
X
Post by
Iseneschal
on May 06, 2024 1:15pm
TCBP....You've all been had....again !!!!
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds 2024-05-06 10:01 ET - News Release TC BioPharm Announces Exercise of Warrants for
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 04, 2024 8:32am
New Press Release - TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
EDINBURGH, Scotland, April 4, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced the execution of a non...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 02, 2024 8:31am
New Press Release - TCBP Increasing Treatment Capacity with Expanded Manufacturing Process
Developing streamlined approach to reduce cost per patient by 85%EDINBURGH, Scotland, April 2, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for...
read article.
(988)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 20, 2024 8:43am
TCBP...might be worth another shot here
On watch ...again
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 19, 2024 8:30am
New Press Release - TCBP Adjourns General Meeting Until a Later Date
EDINBURGH, Scotland, March 19, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has adjourned...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 18, 2024 8:30am
New Press Release - TCBP Announces Exercise of Series D Warrants For Cash
• Company receives gross proceeds of $1.26 M from transactionEDINBURGH, Scotland, March 18, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer...
read article.
(988)
•••
Iseneschal
X
Comment by
Iseneschal
on Mar 11, 2024 3:23pm
RE:TCBP....don't take the bait !!!!!!!!!!
Told ya....$1.67 now 35 mins til close
(988)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 11, 2024 3:08pm
TCBP....don't take the bait !!!!!!!!!!
This is finished....$1.85
(988)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 11, 2024 1:48pm
TCBP....2nd downside target breached ...now at $1.70
Next !!!!!!!!!!!!!!!!!!!!!!!!!!
(988)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 11, 2024 1:32pm
TCBP.....1st downside target breached....now $1.80
Next !!!!!!!!!!!!!!!!!!!!!!!!!!
(988)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 11, 2024 1:19pm
TCBP.....early a.m runner on no news... Sub $2 now
2 scalps....now in PB mode Targets to the downside are ..... $1.88 ....$1.75....$1.53 Good luck....Me no position
(988)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 09, 2024 9:12am
RE:TCBP...early a.m runner on No News
Quick DD....Co regained NASDAQ compliance and Closed P.O recently ...January P.O was at $2 Your call
(988)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 09, 2024 9:06am
TCBP...early a.m runner on No News
big volume on this "thinner"....$1.59 On watch need more DD
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 07, 2023 8:30am
New Press Release - TC BioPharm Shifts Focus to FDA Clinical Trials
Company to explore US IND pathway for additional combination trialsEDINBURGH, Scotland, March 7, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for...
read article.
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A different approach to mineral exploration and development — scale, diversification & optionality
The Future of Junior Mining All in One Place - Get Your Tickets Now!
Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB)
Sekur Private Data CEO Updates on Growth, Market Expansion, Corporate Developments and New Product Launch
Additional government funding secured to advance construction of hydrocarbon condensate refinery
Five key facts you need to know about the Sedna Copper Project
AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U)
Cielo Executes LOI to Advance Clean Fuels Project Development Through Strategic Asset Acquisition
Podcasts